CORXEL Submits NDA for LENZ Therapeutics’ LNZ100 in China, Marking First Global Regulatory Filing for Aceclidine-Based Eye Drop for Presbyopia

LENZ Therapeutics, Inc. a pre-commercial stage biopharmaceutical company focused on the development and commercialization of the first and only aceclidin...

July 29, 2025 | Tuesday | News
Clearside Biomedical Secures Health Canada Approval for XIPERE® in Treating Uveitic Macular Oedema

Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the ...

July 25, 2025 | Friday | News
Ginkgo Bioworks Launches U.S.-Based ADME Profiling Service to Compete with Chinese Vendors on Cost and Scale

Ginkgo Bioworks launches cost-effective, high-throughput ADME profiling service to accelerate small molecule drug discovery with model-ready datasets Gi...

July 18, 2025 | Friday | News
Qualigen Secures Broad Patent Coverage for QN-302 Across Over 20 European Nations, India, China, and Russia

Qualigen Therapeutics, Inc. is announcing an update on patents granted in the first six months of 2025. The patent is Titled “Substitued Naphthalen...

July 17, 2025 | Thursday | News
CARsgen Secures Final EPO Win for GPC3 CAR-T Patent After Appeal Withdrawal

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces a favorable outco...

July 14, 2025 | Monday | News
Golden Age Health and Innostellar Sign Exclusive 10-Year Deal to Deliver Sight-Saving Gene Therapy LX-101 Across China

Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd. (“Innostellar”)  announced an exclusive ten-ye...

July 14, 2025 | Monday | News
Ascentage Pharma Secures China’s First Approval for Bcl-2 Inhibitor in CLL/SLL with Lisaftoclax

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it...

July 11, 2025 | Friday | News
Zhimeng Biopharma Receives CDE Approval to Advance CB03-154 into Phase 2/3 Trials for ALS in China

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and...

July 10, 2025 | Thursday | News
Abinopharm Reports Positive Clinical Trial Outcomes for Oral Dr.Ergo® L-Ergothioneine in Enhancing Skin Health

Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EG...

July 07, 2025 | Monday | News
HUTCHMED and AstraZeneca Secure China Approval for ORPATHYS®–TAGRISSO® Combination in EGFR-Mutant NSCLC with MET Amplification

HUTCHMED (China) Limited  announces that the New Drug Application (“NDA”) for the combination of ORPATHYS® (savolitinib) and TAGRISS...

July 01, 2025 | Tuesday | News
Nutriband and Kindeva Complete Commercial Manufacturing Scale-Up for AVERSA™ Fentanyl, Advancing World’s First Abuse-Deterrent Opioid Patch

Nutriband Inc.  a company engaged in the development of prescription transdermal pharmaceutical products, announced that it has completed commercial...

June 24, 2025 | Tuesday | News
Harbour BioMed and Otsuka Enter $670M+ Global Agreement Across Asia, US, and Europe to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology ...

June 23, 2025 | Monday | News
Innovent Doses First Patient in Phase 3 Trial of Mazdutide for Obstructive Sleep Apnea and Obesity in China

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

June 16, 2025 | Monday | News
Sinovac’s Showdown: Board Fights Back Against Dissident Slate as $55/Share Dividend Hangs in Balance

Sinovac Biotech Ltd. (NASDAQ: SVA), a prominent player in China's biopharmaceutical sector, has entered a defining phase in its corporate history. As the...

June 13, 2025 | Friday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close